Glioblastoma stem cells and Wnt signaling pathway: Molecular mechanisms and therapeutic targets

被引：29
作者：
Guan R. [1 ]
Zhang X. [2 ]
Guo M. [1 ]
机构：
[1] Department of Neurosurgery, Second Affiliated Hospital, Harbin Medical University, 246 Xuefu Road, Nangang, Harbin, Heilongjiang Province
[2] Department of Neurology, Second Affiliated Hospital, Harbin Medical University, Harbin, Heilongjiang Province
来源：
Chinese Neurosurgical Journal | / 6卷 / 1期
基金：
中国国家自然科学基金;
关键词：
D O I：
10.1186/s41016-020-00207-z
中图分类号：
学科分类号：
摘要：
Glioblastoma is the most common form of primary brain tumor. Glioblastoma stem cells play an important role in tumor formation by activation of several signaling pathways. Wnt signaling pathway is one such important pathway which helps cellular differentiation to promote tumor formation in the brain. Glioblastoma remains to be a highly destructive type of tumor despite availability of treatment strategies like surgery, chemotherapy, and radiation. Advances in the field of cancer biology have revolutionized therapy by allowing targeting of tumor-specific molecular deregulation. In this review, we discuss about the significance of glioblastoma stem cells in cancer progression through Wnt signaling pathway and highlight the clinical targets being potentially considered for therapy in glioblastoma. © 2020 The Author(s).
引用
收藏
相关论文
共 77 条
  • [51] Sheldahl L.C., Slusarski D.C., Pandur P., Miller J.R., Kuhl M., Moon R.T., Dishevelled activates Ca2+ flux, PKC, and CamKII in vertebrate embryos, J Cell Biol, 161, 4, pp. 769-777, (2003)
  • [52] Ishitani T., Kishida S., Hyodo-Miura J., Ueno N., Yasuda J., Waterman M., Shibuya H., Moon R.T., Ninomiya-Tsuji J., Matsumoto K., The TAK1-NLK mitogen-activated protein kinase cascade functions in the Wnt-5a/Ca(2+) pathway to antagonize Wnt/beta-catenin signaling, Molecular Cellular Biol, 23, 1, pp. 131-139, (2003)
  • [53] Hogan P.G., Chen L., Nardone J., Rao A., Transcriptional regulation by calcium, calcineurin, and NFAT, Genes Development, 17, 18, pp. 2205-2232, (2003)
  • [54] Nager M., Bhardwaj D., Canti C., Medina L., Nogues P., Herreros J: Beta-catenin signalling in glioblastoma multiforme and glioma-initiating cells, Chemother Res Pract, 2012, (2012)
  • [55] Morris L.G., Kaufman A.M., Gong Y., Ramaswami D., Walsh L.A., Turcan S., Eng S., Kannan K., Zou Y., Peng L., Et al., Recurrent somatic mutation of FAT1 in multiple human cancers leads to aberrant Wnt activation, Nature Genetics, 45, 3, pp. 253-261, (2013)
  • [56] Tang C., Guo J., Chen H., Yao C.J., Zhuang D.X., Wang Y., Tang W.J., Ren G., Yao Y., Wu J.S., Et al., Gene mutation profiling of primary glioblastoma through multiple tumor biopsy guided by 1H-magnetic resonance spectroscopy, Int J Clin Exp Pathol, 8, 5, pp. 5327-5335, (2015)
  • [57] Dikshit B., Irshad K., Madan E., Aggarwal N., Sarkar C., Chandra P.S., Gupta D.K., Chattopadhyay P., Sinha S., Chosdol K., FAT1 acts as an upstream regulator of oncogenic and inflammatory pathways, via PDCD4, in glioma cells, Oncogene, 32, 33, pp. 3798-3808, (2013)
  • [58] Madan E., Dikshit B., Gowda S.H., Srivastava C., Sarkar C., Chattopadhyay P., Sinha S., Chosdol K., FAT1 is a novel upstream regulator of HIF1alpha and invasion of high grade glioma, Int J Cancer, 139, 11, pp. 2570-2582, (2016)
  • [59] Sareddy G.R., Pratap U.P., Viswanadhapalli S., Venkata P.P., Nair B.C., Krishnan S.R., Zheng S., Gilbert A.R., Brenner A.J., Brann D.W., Et al., PELP1 promotes glioblastoma progression by enhancing Wnt/β-catenin signaling, Neuro-Oncology Advances, 1, 1, (2019)
  • [60] Shaji S.K., Sunilkumar D., Mahalakshmi N.V., Kumar G.B., Nair B.G., Analysis of microarray data for identification of key microRNA signatures in glioblastoma multiforme, Oncology Letters, 18, 2, pp. 1938-1948, (2019)
12345678